GlassScriptPhysician profile
Maria Imran
NPI 1174333157
$2,252.32
in general payments reported to CMS, 2019-2025
9 companies · $2,252 in 2025
The $2,252 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,115 · Food and Beverage: $1,092 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,115.01 |
| Food and Beverage | $1,092.31 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,242.64 | 2025 | Proclaim, Eterna |
| Medtronic, INC. | $465.56 | 2025 | Intellis Adaptivestim |
| Nalu Medical, INC. | $254.09 | 2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.76 | 2025 | Relistor |
| Collegium Pharmaceutical, INC. | $65.78 | 2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $65.03 | 2025 | Sprint Pns System |
| Boston Scientific Corporation | $38.21 | 2025 | General - Pain Management |
| Valinor Pharma, LLC | $25.30 | 2025 | Movantik |
| Averitas Pharma INC. | $13.95 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Imran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.